Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of MCM6 predicts poor survival in patients with glioma

9 May 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to DNA Repair Mechanisms
Share to Glioma Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29753008
DOI: 10.1016/j.humpath.2018.04.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of MCM6 predicts poor survival in patients with gliomaPMID 29753008Read ↗

MCM5 is an oncogenic driver in glioma progression through regulating cell cycleSemantic proximity Read ↗

CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomasSemantic proximity Read ↗

HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferationSemantic proximity Read ↗

MCM4 is a novel prognostic biomarker and promotes cancer cell growth in gliomaSemantic proximity Read ↗

PAX6 suppresses growth of human glioblastoma cellsSemantic proximity Read ↗

MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastomaSemantic proximity Read ↗

Low expression of GALNT6 gene in gliomas promotes immune infiltration and improves tumor prognosis using bioinformatics analysisSemantic proximity Read ↗

TRIM6: An Upregulated Biomarker with Prognostic Significance and Immune Correlations in GliomasSemantic proximity Read ↗

MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastomaSemantic proximity Read ↗

High Expression of PRMT6 Associated With Prognosis and Immune Infiltration in GliomaSemantic proximity Read ↗

High PRMT6 expression Associated With Prognosis and Immune Infiltration in GliomaSemantic proximity Read ↗

CDC6 is a prognostic biomarker and correlated with immune infiltrates in gliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.